TETMODIS

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Lithuania, Netherlands, Poland, Romania, Spain.

Active ingredients

The drug TETMODIS contains one active pharmaceutical ingredient (API):

1	Tetrabenazine UNII Z9O08YRN8O - TETRABENAZINE
	Tetrabenazine is a synthetic derivative of benzylquinolizine that causes depletion of dopamine and other monoamines in the central nervous system. The precise mechanism by which tetrabenazine exerts its effects is unknown, but is believed to be related to its effect as a reversible depletor of monoamines (such as dopamine, serotonin, norepinephrine, and histamine) from nerve terminals. Neurotransmitter depletion by a single dose of tetrabenazine is reversible and lasts only a few hours.
	Read more about Tetrabenazine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07XX06	Tetrabenazine	N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1343898
ES	Centro de información online de medicamentos de la AEMPS	72730
FI	Lääkealan turvallisuus- ja kehittämiskeskus	579381
FR	Base de données publique des médicaments	64487229
HR	Agencija za lijekove i medicinske proizvode	HR-H-895447033
LT	Valstybinė vaistų kontrolės tarnyba	1031787
NL	Z-Index G-Standaard, PRK	50725
PL	Rejestru Produktów Leczniczych	100232990
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60126001